Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER G WANG

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1083856157
CMS profile
1304108
Location
BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$2,694.40

141 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,694.40 141

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $252.00 16
AstraZeneca Pharmaceuticals LP $203.33 9
Merck Sharp & Dohme LLC $192.19 9
Takeda Pharmaceuticals U.S.A., Inc. $169.51 8
Celgene Corporation $142.86 9
Janssen Biotech, Inc. $113.22 5
Seagen Inc. $106.20 6
Genentech USA, Inc. $97.30 5
PFIZER INC. $77.08 5
Lilly USA, LLC $76.17 4
Exelixis Inc. $71.04 3
Regeneron Healthcare Solutions, Inc. $68.13 3
Bayer Healthcare Pharmaceuticals Inc. $62.80 3
Octapharma USA, Inc. $60.11 3
Mirati Therapeutics, Inc. $54.94 3
Pharmacyclics LLC, An AbbVie Company $51.25 3
Astellas Pharma US Inc $50.40 3
GlaxoSmithKline, LLC. $49.36 3
BeiGene USA, Inc. $48.52 3
Ipsen Biopharmaceuticals, Inc $48.41 2
E.R. Squibb & Sons, L.L.C. $47.14 3
Gilead Sciences, Inc. $44.35 2
Blueprint Medicines Corporation $43.95 2
GENZYME CORPORATION $40.37 2
AbbVie Inc. $38.47 2
AVEO Pharmaceuticals, Inc. $37.15 2
Kite Pharma, Inc. $36.98 2
Myriad Genetic Laboratories, Inc. $33.58 2
TerSera Therapeutics LLC $32.98 1
PharmaEssentia USA Corporation $31.59 1
Genmab U.S., Inc. $30.30 2
TAIHO ONCOLOGY, INC. $24.79 1
Pharmacosmos Therapeutics Inc. $22.82 1
Daiichi Sankyo Inc. $22.56 1
ADC Therapeutics America, Inc. $22.13 1
Alexion Pharmaceuticals, Inc. $20.80 1
MorphoSys, US Inc. $19.70 1
Apellis Pharmaceuticals, Inc. $19.06 1
Eisai Inc. $18.85 1
Deciphera Pharmaceuticals Inc. $18.64 1
Adaptive Biotechnologies Corporation $18.10 1
ImmunoGen, Inc. $16.31 1
ACCORD HEALTHCARE, INC. $15.50 1
Sumitomo Pharma America, Inc. $15.37 1
Amgen Inc. $15.16 1
ARRAY BIOPHARMA INC $12.93 1

Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER G WANG

NPI 1083856157 · CMS profile ID 1304108

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1083856157?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER G WANG, NPI 1083856157, CMS profile ID 1304108. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1083856157?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). CHRISTOPHER G WANG, NPI 1083856157, CMS profile ID 1304108. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1083856157?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
CHRISTOPHER G WANG, NPI 1083856157, CMS profile ID 1304108, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1083856157?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

141 matching records · $2,694.40 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 141 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 141.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie Inc. $16.7908/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999504499 CMS
Seagen Inc. $12.8108/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995807807 CMS
Novartis Pharmaceuticals Corporation $16.1308/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993271267 CMS
Merck Sharp & Dohme LLC $21.6708/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048539507 CMS
Merck Sharp & Dohme LLC $29.9508/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048539527 CMS
Merck Sharp & Dohme LLC $17.1308/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048884967 CMS
Novartis Pharmaceuticals Corporation $27.4108/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993271261 CMS
Novartis Pharmaceuticals Corporation $8.5308/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993271259 CMS
Astellas Pharma US Inc $17.7808/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034382437 CMS
ImmunoGen, Inc. $16.3108/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017247119 CMS
Celgene Corporation $21.2208/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016255301 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.8407/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055659545 CMS
Eisai Inc. $18.8507/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023305605 CMS
Genentech USA, Inc. $15.6807/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040329575 CMS
Genentech USA, Inc. $21.2807/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040329593 CMS
Blueprint Medicines Corporation $22.8207/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051259789 CMS
Myriad Genetic Laboratories, Inc. $16.0607/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059801551 CMS
AVEO Pharmaceuticals, Inc. $22.6007/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049057445 CMS
Genmab U.S., Inc. $15.8907/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343475 CMS
Janssen Biotech, Inc. $28.3307/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987998879 CMS
Celgene Corporation $19.8507/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016255307 CMS
Genentech USA, Inc. $21.7807/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040329581 CMS
ACCORD HEALTHCARE, INC. $15.5006/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052308439 CMS
Octapharma USA, Inc. $23.2406/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042738027 CMS
Octapharma USA, Inc. $16.2906/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042738033 CMS
PharmaEssentia USA Corporation $31.5906/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059305603 CMS
Ipsen Biopharmaceuticals, Inc $23.9806/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045431447 CMS
Merck Sharp & Dohme LLC $21.0206/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048813499 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.1206/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055659539 CMS
Exelixis Inc. $23.2706/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044570063 CMS
Pharmacyclics LLC, An AbbVie Company $17.6006/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998297547 CMS
Deciphera Pharmaceuticals Inc. $18.6406/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053722035 CMS
Astellas Pharma US Inc $13.7006/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034133329 CMS
Janssen Biotech, Inc. $20.0906/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987998911 CMS
Mirati Therapeutics, Inc. $20.9105/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058005991 CMS
Novartis Pharmaceuticals Corporation $23.2105/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993271257 CMS
GENZYME CORPORATION $20.3905/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050233521 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.7905/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055659533 CMS
Astellas Pharma US Inc $18.9205/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034116541 CMS
AstraZeneca Pharmaceuticals LP $16.4305/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016057851 CMS
BeiGene USA, Inc. $14.8205/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051183259 CMS
Regeneron Healthcare Solutions, Inc. $20.6505/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999522921 CMS
Merck Sharp & Dohme LLC $21.5304/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048539515 CMS
AstraZeneca Pharmaceuticals LP $20.5604/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011891477 CMS
Celgene Corporation $20.5704/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016255259 CMS
PFIZER INC. $17.2304/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050379931 CMS
Alexion Pharmaceuticals, Inc. $20.8004/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016997703 CMS
TAIHO ONCOLOGY, INC. $24.7904/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055227699 CMS
Blueprint Medicines Corporation $21.1304/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051259675 CMS
Seagen Inc. $17.8904/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995807579 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,993.73 189
PY2020 $1,906.86 125
PY2021 $4,641.31 171
PY2022 $2,891.96 161
PY2023 $2,694.40 141
PY2024 $3,572.99 187
PY2025 $3,313.28 162

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $24,147.35 6
PY2024 Principal investigator $5,053.64 3
PY2023 Principal investigator $89,712.52 4
PY2021 Principal investigator $282.50 1
PY2020 Principal investigator $30.40 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $680.00 12/09/2025 Non-covered Recipient Entity
Alabama Oncology
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE PF08046054SGNPDL1V VERSUS DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLYTREATED PROGRAMMED CELL DEATH LIGAND 1 PDL1 POSITIVE NONSMALLCELL LUNG CANCER NSCLC No dispute reported 06/30/2026 1228715935
Principal investigator 1 PFIZER INC. $680.00 12/09/2025 Non-covered Recipient Entity
Alabama Oncology
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE PF08046054SGNPDL1V VERSUS DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLYTREATED PROGRAMMED CELL DEATH LIGAND 1 PDL1 POSITIVE NONSMALLCELL LUNG CANCER NSCLC No dispute reported 06/30/2026 1228715937
Principal investigator 1 PFIZER INC. $2,750.00 11/27/2025 Non-covered Recipient Entity
ALABAMA ONCOLOGY
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE PF08046054SGNPDL1V VERSUS DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLYTREATED PROGRAMMED CELL DEATH LIGAND 1 PDL1 POSITIVE NONSMALLCELL LUNG CANCER NSCLC No dispute reported 06/30/2026 1228733844
Principal investigator 1 PFIZER INC. $12,679.00 08/11/2025 Non-covered Recipient Entity
ALABAMA ONCOLOGY
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE SGNB6A COMPARED WITH DOCETAXEL IN ADULT SUBJECTS WITH PREVIOUSLY TREATED NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228766781
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,400.00 06/18/2025 Non-covered Recipient Entity
Birmingham Hematology And Oncology Ass,llc
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE) No dispute reported 06/30/2026 1235998600
Principal investigator 1 Mirati Therapeutics, Inc. $5,958.35 04/28/2025 Non-covered Recipient Entity
Birmingham Hematology And Oncology Ass,llc
A Randomized Phase 3 Study of MRTX849 in Combination With Cetuximab Versus Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation With Disease Progression On or After Standard First-Line Therapy No dispute reported 06/30/2026 1236531248